Zhixiang Gao

Zhixiang Gao

Auto-generated profile, based on publicly available information

Zhixiang Gao

Department of Urology Zhangjiagang Hospital Affiliated to Soochow University Suzhou China

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
ZMZun Mao
Zun Mao
ZGZhixiang Gao
Zhixiang Gao
RLRuyu Long
Ruyu Long
HGHuimin Guo
Huimin Guo
LCLong Chen
Long Chen
GYGuoping Yin
Guoping Yin
Background and aims: The mitotic catastrophe (MC) pathway plays an important role in hepatocellular carcinoma (HCC) progression and tumor microenvironment (TME) regulation. However, the mechanisms linking MC heterogeneity to immune evasion and treatment response remain unclear.Methods: Based on 94 previously published highly correlated genes for MC, HCC patients’ data from the Cancer Genome Atlas (TCGA) and changes in immune signatures and prognostic stratification were studied. Time and spatial-specific differences for MCGs were assessed by single-cell RNA sequencing and spatial transcriptome (ST) analysis. Multiple external databases (GEO, ICGC) were employed to construct an MC-related riskscore model.Results: Identification of two MC-related subtypes in HCC patients from TCGA, with clear differences in immune signatures and prognostic risk stratification. Spatial mapping further associates low MC tumor regions with significant immune escape-related signaling. Nomogram combining MC riskscore and traditional indicators was validated great effect for early prediction of HCC patient outcomes.Conclusion: MC heterogeneity enables immune escape and therapy resistance in HCC. The MC gene signature serves as a reliable prognostic indicator for liver cancer. By revealing clear immune and spatial heterogeneity of HCC, our integrated approach provides contextual therapeutic strategies for optimal clinical decision-making.

15 December 2024 in Journal of International Medical Research
Verified
Journal Article
Open access
ZGZhixiang Gao
Zhixiang Gao
YDYue Ding
Yue Ding
HLHaiyong Liu
Haiyong Liu
RDRenji Du
Renji Du
ZSZhiwei Sun
Zhiwei Sun
RWRong Wang
Rong Wang
Objective: To compare the safety and efficacy of low-power (LP) and high-power (HP) holmium laser enucleation of the prostate (HoLEP) in patients with symptomatic small-volume benign prostatic hyperplasia (BPH). Methods: In this prospective, multicenter, single-blind, randomized controlled trial, men with symptomatic BPH (prostate volume <40 mL, peak urinary flow rate [Qmax] <10 mL/s, International Prostate Symptom Score [IPSS] ≥18) underwent either LP (24 W) or HP HoLEP (80 W). The primary outcome was IPSS at 6 months postoperatively. Secondary outcomes included the surgical duration, total laser energy, enucleated prostate weight, patient-reported outcomes, and Clavien–Dindo classification of complications at 1, 3, and 6 months after surgery. Results: Eighty-one participants completed the study. LP HoLEP used significantly less energy (22.4 ± 10.4 kJ vs. 58.6 ± 17.8 kJ). Postoperative pain was lower in the LP group at 24 and 48 hours. Both groups displayed significant improvements in outcomes versus baseline including IPSS and Qmax. The incidence of intraoperative complications was similar, though minor capsular perforation occurred exclusively in the HP group (9.8%). Conclusion: LP HoLEP produced comparable clinical outcomes as HP HoLEP for small-volume BPH while using less energy, supporting its use for smaller glands.

20 May 2025 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
RWRong Wang
Rong Wang
MXMeng Xia
Meng Xia
ZGZhixang Gao
Zhixang Gao
XYXuehua Yu
Xuehua Yu
AGAihua Guo
Aihua Guo

4 August 2025 in Engineering Reports
Verified
Journal Article
Open access
RWRong Wang
Rong Wang
YDYue Ding
Yue Ding
YSYajun Shen
Yajun Shen
HLHaiyong Liu
Haiyong Liu
PWPing Wang
Ping Wang
ZGZhixiang Gao
Zhixiang Gao
Prostate cancer remains one of the most common malignancies affecting men globally, characterized by high morbidity and mortality rates. The complexity and variability of the disease necessitate diverse treatment strategies, ranging from active surveillance to more aggressive interventions such as radical prostatectomy, radiation therapy, and androgen deprivation therapy. This study investigates the potential of large language models (LLMs) in generating educational content for prostate cancer, focusing on the creation of teaching plans in both Chinese and English. Four LLMs—GPT‐4 (OpenAI), Gemini 1.5 Pro (Google), Kimi AI (Microsoft), and Douban (ByteDance)—were evaluated against teaching plans developed by an experienced urology professor. A double‐blind assessment by 25 urology faculty members using a standardized 10‐point scale was employed to compare the quality of curriculum content, learning objectives, and outcomes. The results revealed that GPT‐4 and Gemini 1.5 Pro outperformed Kimi AI and Douban, yet still lagged behind human‐generated plans, particularly in Chinese. Statistical analyses indicated significant differences in the quality scores among the LLMs and the human experts, underscoring the necessity of integrating domain‐specific knowledge into AI‐generated content. This research highlights the promise and limitations of LLMs in medical education, suggesting that future developments should focus on hybrid models that combine artificial intelligence with human expertise to enhance educational efficacy.